Helminth egg derivatives as proregenerative immunotherapies

The immune system is increasingly recognized as an important regulator of tissue repair. We developed a regenerative immunotherapy from the helminth soluble egg antigen (SEA) to stimulate production of interleukin (IL)-4 and other type 2-associated cytokines without negative infection-related sequel...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 120; no. 8; p. e2211703120
Main Authors: Maestas, Jr, David R, Chung, Liam, Han, Jin, Wang, Xiaokun, Sommerfeld, Sven D, Kelly, Sean H, Moore, Erika, Nguyen, Helen Hieu, Mejías, Joscelyn C, Peña, Alexis N, Zhang, Hong, Hooks, Joshua S T, Chin, Alexander F, Andorko, James I, Berlinicke, Cynthia A, Krishnan, Kavita, Choi, Younghwan, Anderson, Amy E, Mahatme, Ronak, Mejia, Christopher, Eric, Marie, Woo, JiWon, Ganguly, Sudipto, Zack, Donald J, Zhao, Liang, Pearce, Edward J, Housseau, Franck, Pardoll, Drew M, Elisseeff, Jennifer H
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 21-02-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The immune system is increasingly recognized as an important regulator of tissue repair. We developed a regenerative immunotherapy from the helminth soluble egg antigen (SEA) to stimulate production of interleukin (IL)-4 and other type 2-associated cytokines without negative infection-related sequelae. The regenerative SEA (rSEA) applied to a murine muscle injury induced accumulation of IL-4-expressing T helper cells, eosinophils, and regulatory T cells and decreased expression of IL-17A in gamma delta (γδ) T cells, resulting in improved repair and decreased fibrosis. Encapsulation and controlled release of rSEA in a hydrogel further enhanced type 2 immunity and larger volumes of tissue repair. The broad regenerative capacity of rSEA was validated in articular joint and corneal injury models. These results introduce a regenerative immunotherapy approach using natural helminth derivatives.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by David J. Mooney, Harvard University, Cambridge, MA; received July 19, 2022; accepted January 11, 2023 by Editorial Board Member Rakesh K. Jain
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2211703120